title1  
〜 for モバイル 〜
http://www.yakuzaishi-kyujin.com/

ホーム   Myページ

 
05/17  Chantix (varenicline)
FDA MedWatch
.
 
05/17  Chantix (varenicline)
FDA MedWatch
.
UPDATE - Prescribing information revised to include safety information regarding serious neuropsychiatric symptoms in the WARNINGS and PRECAUTIONS sections of the label. Additionally, a Medication Guide for patients is available.
   この記事へ» この記事の翻訳へ»
 
05/17  ASH: Novel Compound Attacks Hypertension on Two Fronts
MedPage Today
.
 
05/17  ASH: Novel Compound Attacks Hypertension on Two Fronts
MedPage Today
.
NEW ORLEANS -- A compound that blocks angiotensin and endothelin receptors, which are believed to promote hypertension, reduced mean ambulatory systolic pressure by 14.8 mm Hg, researchers reported here.
   この記事へ» この記事の翻訳へ»
 
05/17  mTOR Inhibitor Delays Progression of Metastatic R ...
MedPage Today
.
 
05/17  mTOR Inhibitor Delays Progression of Metastatic R ...
MedPage Today
.
NEW YORK -- More than 60% of metastatic kidney cancer patients taking an investigational mTOR inhibitor had a delay in progression of their disease, researchers here said.
   この記事へ» この記事の翻訳へ»
 
05/17  HRS: Statins Linked to Lower Atrial Fibrillation  ...
MedPage Today
.
 
05/17  HRS: Statins Linked to Lower Atrial Fibrillation  ...
MedPage Today
.
SAN FRANCISCO -- Women taking statins with a history of coronary disease may be at a lower risk of developing atrial fibrillation, researchers found.
   この記事へ» この記事の翻訳へ»
 
05/17  Missing Mutations Hold Clue to Imatinib (Gleevec) ...
MedPage Today
.
 
05/17  Missing Mutations Hold Clue to Imatinib (Gleevec) ...
MedPage Today
.
PHILADELPHIA -- Some patients with gastrointestinal stromal tumors (GIST) who are imatinib (Gleevec)-resistant don't respond because they are missing the mutations in two genes that are usually integral to the illness. Now researchers here have found out what may be causing their disease.
   この記事へ» この記事の翻訳へ»

画面上へ
ホーム   Myページ


お問い合わせ(メール)
お問い合わせ(電話:平日10〜18時)
会社概要
プライバシーポリシー
個人情報保護法
サイトマップ

(c) 薬剤師求人.com  by  Fortune Inc.